Alnylam Pharmaceuticals Inc (ALNY)

242.50 -0.75 (-0.31%) USD  |  NASDAQ  |  Dec 26, 16:00
242.00 -0.50 (-0.21%) After-Hours: 20:00
More

Alnylam Pharmaceuticals EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Current Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Earnings Per Share Estimates Definition

View Earnings Per Share Estimates Definition
Start Trial

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

View EPS Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Fiscal Year Benchmarks

View EPS Estimates for Current Fiscal Year Benchmarks
Start Trial
Pfizer Inc Upgrade
BridgeBio Pharma Inc Upgrade
Gilead Sciences Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Sarepta Therapeutics Inc Upgrade

EPS Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade